Agnieszka Blazejczyk
Overview
Explore the profile of Agnieszka Blazejczyk including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
8
Citations
94
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Szafraniec J, Blazejczyk A, Kus E, Janik M, Zajac G, Wietrzyk J, et al.
Nanoscale
. 2017 Nov;
9(47):18867-18880.
PMID: 29177344
The design of nanodelivery systems has been recently considered as a solution to the major challenge in pharmaceutical research - poor bioavailability of lipophilic drugs. Nanocapsules with liquid oil cores...
2.
Kania G, Sternak M, Jasztal A, Chlopicki S, Blazejczyk A, Nasulewicz-Goldeman A, et al.
Nanomedicine
. 2017 Sep;
14(1):131-140.
PMID: 28939490
Bioreactivity of superparamagnetic iron oxide nanoparticles (SPION) coated with thin layers of either cationic or anionic chitosan derivatives and serving as contrast agents in magnetic resonance imaging (MRI) was studied...
3.
Kalaska B, Kaminski K, Miklosz J, Yusa S, Sokolowska E, Blazejczyk A, et al.
Transl Res
. 2016 Jul;
177:98-112.e10.
PMID: 27456749
The parenteral anticoagulants may cause uncontrolled and life-threatening bleeding. Protamine, the only registered heparin antidote, is partially effective against low-molecular weight heparins, completely ineffective against fondaparinux and may cause unacceptable...
4.
Blazejczyk A, Switalska M, Chlopicki S, Marcinek A, Gebicki J, Nowak M, et al.
J Exp Clin Cancer Res
. 2016 Jul;
35(1):110.
PMID: 27412454
Background: 1-methylnicotinamide (1-MNA), an endogenous metabolite of nicotinamide, has recently gained interest due to its anti-inflammatory and anti-thrombotic activities linked to the COX-2/PGI2 pathway. Given the previously reported anti-metastatic activity...
5.
Sokolowska E, Kalaska B, Kaminski K, Lewandowska A, Blazejczyk A, Wietrzyk J, et al.
Front Pharmacol
. 2016 Mar;
7:60.
PMID: 27014072
Though protamine sulfate is the only approved antidote of unfractionated heparin (UFH), yet may produce life threatening side effects such as systemic hypotension, catastrophic pulmonary vasoconstriction or allergic reactions. We...
6.
3D Raman imaging of systemic endothelial dysfunction in the murine model of metastatic breast cancer
Pacia M, Buczek E, Blazejczyk A, Gregorius A, Wietrzyk J, Chlopicki S, et al.
Anal Bioanal Chem
. 2016 Mar;
408(13):3381-7.
PMID: 26935932
It was recently reported in the murine model of metastatic breast cancer (4T1) that tumor progression and development of metastasis is associated with systemic endothelial dysfunction characterized by impaired nitric...
7.
Przygodzki T, Talar M, Blazejczyk A, Kalchenko V, Watala C
PLoS One
. 2016 Jan;
11(1):e0146346.
PMID: 26751810
Introduction: The paper describes an alternative method for quantification of in vivo ADP-induced thromboembolism. The aim of the studies was to develop a method of quantification which would not require...
8.
Blazejczyk A, Papiernik D, Porshneva K, Sadowska J, Wietrzyk J
Pharmacol Rep
. 2015 Sep;
67(4):711-8.
PMID: 26321272
Endothelial cells accompany the malignant cancer cell in almost every stage of metastatic process which includes: infiltration of tumor cells into the neighboring tissue, transmigration through endothelium (intravasation), survival in...